RECRUITING

HPV Self-Collection Program

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The objective of the study is to develop, pilot, and analyze the effectiveness of HPV self-collection programs which will be used to follow up among women overdue for cervical cancer screening. The investigators will develop protocols for in-clinic and home-based HPV-self-collection programs and follow-up system for HPV-positive tests for community health centers and/or clinics. The program is meant to mail HPV-self-collection kits to women who are due and/or overdue for cervical cancer screening and the program is also meant to present women seen in clinic with a self-collection option for screening alongside a Pap test option. The research team will develop related informational resources on how to complete the test as well as information on screening options. The study will neither experiment nor test the effectiveness of the self-collection process nor the assay of specimens for HPV and high-risk HPV strains. It is not a clinical investigation to assess the safety or effectiveness of a medical device. The study is implementation science and seeks to find optimal ways to implement this World Health Organization recommended screening option.

Official Title

HPV Self-Collection Program

Quick Facts

Study Start:2024-10-18
Study Completion:2025-10-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06674681

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:25 Years to 65 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Women and individuals with a cervix.
  2. * Aged 25-65 years during the study measurement period.
  3. * Qualifying visit to the participating clinic.
  4. * Overdue for cervical cancer screening.
  5. * Those aged 24-64 who have not had cervical cytology (i.e., Pap test) performed within the last three and a half (3.5) years, or those aged 30-65 who have not had cervical HPV testing (i.e., primary HPV testing or contesting for HPV with Pap test) performed within the last five and a half (5.5) years.
  1. * Individuals without a cervix.
  2. * Receiving hospice and/or palliative care during any part of the measurement period.

Contacts and Locations

Study Contact

Deanna Kepka
CONTACT
801-587-4565
Deanna.Kepka@hci.utah.edu

Principal Investigator

Deanna Kepka, PhD, MPH
PRINCIPAL_INVESTIGATOR
University of Utah

Study Locations (Sites)

University of Utah Health Hospitals/Huntsman Cancer Institute Population Sciences
Salt Lake City, Utah, 84112
United States

Collaborators and Investigators

Sponsor: University of Utah

  • Deanna Kepka, PhD, MPH, PRINCIPAL_INVESTIGATOR, University of Utah

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-18
Study Completion Date2025-10-30

Study Record Updates

Study Start Date2024-10-18
Study Completion Date2025-10-30

Terms related to this study

Additional Relevant MeSH Terms

  • HPV